Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Botulinum toxin type A
placebo
Locations
5
Germany
Praxisklinik Ulmenhof
Hamburg, Germany
Fondazione IRCCS Istituto Neurologico Carlo Besta (CBNI)
Milan, Italy
St Olavs Hospital
Trondheim, Norway
Department of Neurology, University Clinic Hospital. Catholic University of Valencia
Valencia, Spain
National Hospital of Neurology and Neurosurgery, University College of London
London, United Kingdom
Start Date
November 1, 2019
Primary Completion Date
September 1, 2025
Completion Date
September 1, 2025
Last Updated
November 19, 2024
NCT02910323
NCT06277063
NCT04939922
NCT06583395
NCT07370142
NCT06841627
Lead Sponsor
Norwegian University of Science and Technology
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions